Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Megakines - novel tools for structural insight into receptor:chemokine complexes

Project description

Megakines as a tool for the structural analysis of receptor:chemokine complexes

Chemokines are small, secreted cytokines that activate membrane receptors of the G protein-coupled receptor superfamily. The chemokine–receptor interactions control many physiological processes and are implicated in many pathologies, including atherosclerosis, inflammatory diseases, HIV infection and cancer. The interactions of 50 chemokines and 20 receptors identified in humans require precise orchestration as a chemokine may bind to several receptors, while a single chemokine receptor has multiple ligands. Cryo-electron microscopy is a ground-breaking technique for elucidating molecular structures, but the analysis of small proteins like receptor:chemokine complexes is still challenging. The EU-funded MEGAKINE project proposes an innovative approach to increase chemokine size through a rigid insertion into a bulky scaffold protein, creating megakines to facilitate the structural analysis of chemokine receptors.

Objective

Chemokines are small, secreted cytokines that activate membrane receptors belonging to the G protein-coupled receptor (GPCR) superfamily. The chemokine-receptor interactions control crucial physiological processes, but are also implicated in many pathologies, including atherosclerosis, inflammatory diseases, HIV infection or cancer, and hold a great potential for therapeutic intervention.
Yet, although GPCRs are the target of about one third of currently marketed drugs, only three of them act on chemokine receptors, essentially due to poor structural understanding of the intricate interactions with their ligands. Indeed, about 50 chemokines and 20 receptors have been identified in humans. Their interactions require precise orchestration, as a chemokine may bind to several receptors, while a single chemokine receptor has multiple ligands. However, the structural determinants dictating ligand specificity and receptor activation remain elusive.
Lately, cryo-EM has emerged as a ground-breaking technique for elucidating molecular structures but despite recent advancements, analysis of small proteins like receptor:chemokine complexes (∼50 kDa) is still challenging. In this project, we propose an innovative approach to increase the chemokine size, without altering its functionality, through a rigid insertion into a bulky scaffold protein. Such enlarged chemokines, called Megakines, will facilitate structural analysis of chemokine receptors.
To prove this concept, we will first reformat the well-characterized chemokine CCL5 and use it in structural/functional studies with two clinically relevant receptors, CCR5 and ACKR2.
The achievement of this project relies on the multidisciplinary combination of the excellent expertise in the chemokine field of the host laboratory and the protein engineering skills of the applicant. The proposed Megakine technology has the potential to revolutionize cryo-EM studies of chemokine receptors and facilitate the therapeutic development.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-MSCA-IF-2019

See all projects funded under this call

Coordinator

LUXEMBOURG INSTITUTE OF HEALTH
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 178 320,00
Address
1A RUE RUE THOMAS EDISON
1445 Strassen
Luxembourg

See on map

Region
Luxembourg Luxembourg Luxembourg
Activity type
Research Organisations
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 178 320,00
My booklet 0 0